News Releases

Date Title
04/24/2018 Summary ToggleEnanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended March 31, 2018
04/12/2018 Summary ToggleEnanta to Present New Data for Core Inhibitor for Hepatitis B Virus and FXR Agonist EDP-305 for NASH at The International Liver Congress™ 2018
03/28/2018 Summary ToggleEnanta Pharmaceuticals Announces Data Presentations at The International Liver Congress™ 2018
03/06/2018 Summary ToggleEnanta Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright NASH Investor Conference
02/12/2018 Summary ToggleEnanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
02/07/2018 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017
01/24/2018 Summary ToggleEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2017
01/05/2018 Summary ToggleEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Business Outlook for 2018 during the 36th Annual J.P. Morgan Healthcare Conference
12/28/2017 Summary ToggleEnanta Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
12/21/2017 Summary ToggleEnanta Pharmaceuticals Announces Data Presentations at the 2018 NASH-TAG Conference